Under the banner “Catalyzing Collaborations for Global Impact,” the CONNECT Nordics symposium challenged European actors to move beyond borders and build the partnerships needed to drive the next generation of cancer innovation.
The Cell Therapy Innovation Symposium gathered scientists, process developers, and industry leaders from across Europe to explore the latest advances and challenges in immune cell therapy manufacturing.
Oslo Cancer Cluster brought together leading experts from across the Nordics, the UK, and the US for a full-day symposium focused on lung cancer screening.
Scientists are developing new CAR-T cell therapy in their laboratories located at Oslo Cancer Cluster Incubator.
The PREDI-LYNCH project kicks off in Heidelberg.
The partnership between Oslo Cancer Cluster and Ullern Upper Secondary School marks its 15th anniversary in 2025. The milestone was celebrated at Oslo Cancer Cluster Innovation Park on 15 September with a lively programme.
Get monthly news updates and invitations to events from our oncology cluster.
AdjuTec Pharma has been awarded a €2.2 million Eurostars grant together with international partners. The funding will support the development of new drug combinations for patients suffering from severe lung infections caused by multidrug-resistant bacteria.
The Norwegian Cancer Society is pleased to announce the opening of nominations for its 2025 Innovation Prize.
Hvordan nå de helsepolitiske ambisjonene samtidig som vi prioriterer riktig? Dette var hovedspørsmålet på frokostseminaret Fremtidens kreftbehandling under Arendalsuka 2025.
Årets postersesjon for elevene på Forskerlinja ble en like vellykket affære som alltid. Solen skinte fra skyfri himmel og åtte forskningsprosjekter ble satt pris på av henholdsvis mentorer og medelever. Høyt engasjement og god stemning preget seansen.
Over 70 participants gathered at the CONNECT Summer Meeting to align efforts around precision oncology in Norway.
We gathered our members and friends to kick off the summer season. See the pictures.
